Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ReNerve.
RELATED STOCKHEAD STORIES
Stockhead TV
Break it Down: ReNerve’s exclusive Middle East move
Health & Biotech
Health Check: The robots are taking over biotech stock selection
Health & Biotech
ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns
Health & Biotech
ReNerve inks deal to expand nerve-repair product in Hong Kong and Macau
Health & Biotech
Health Check: No sign of frayed nerves as Orthocell girds for US approval
Health & Biotech
Scott Power: Which ASX healthcare stock has soared 30pc this week?
Stockhead TV
Long Shortz with ReNerve: Welcome to the ASX
Health & Biotech
Health Check: Biotech double-banger breaks the IPO drought
Health & Biotech
